

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.66206130 |
| 2 | vocalization behavior (GO:0071625) | 5.36095798 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.19544772 |
| 4 | behavioral response to nicotine (GO:0035095) | 4.91067030 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.86712711 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.84734687 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.78744908 |
| 8 | protein localization to synapse (GO:0035418) | 4.78366396 |
| 9 | presynaptic membrane assembly (GO:0097105) | 4.64436716 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.63600140 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.60296718 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.57983843 |
| 13 | response to histamine (GO:0034776) | 4.51962359 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.37319181 |
| 15 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.34189959 |
| 16 | presynaptic membrane organization (GO:0097090) | 4.24022869 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13442205 |
| 18 | postsynaptic membrane organization (GO:0001941) | 4.11964476 |
| 19 | neuron recognition (GO:0008038) | 4.11674796 |
| 20 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.06195799 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 4.03159626 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.01329014 |
| 23 | glutamate secretion (GO:0014047) | 3.94958612 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 3.92916974 |
| 25 | axonal fasciculation (GO:0007413) | 3.84274942 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 3.83087970 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.79394497 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.78977496 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.78856820 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.75878761 |
| 31 | neuronal action potential propagation (GO:0019227) | 3.73330831 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.72200691 |
| 33 | proline transport (GO:0015824) | 3.70643123 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.68291547 |
| 35 | startle response (GO:0001964) | 3.67873587 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67658814 |
| 37 | locomotory exploration behavior (GO:0035641) | 3.67481095 |
| 38 | serotonin metabolic process (GO:0042428) | 3.65069047 |
| 39 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.58690546 |
| 40 | behavioral response to cocaine (GO:0048148) | 3.57587180 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 3.54843118 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.54091203 |
| 43 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.51615009 |
| 44 | regulation of glutamate secretion (GO:0014048) | 3.50405043 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45607297 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.44641255 |
| 47 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.42412172 |
| 48 | exploration behavior (GO:0035640) | 3.41693432 |
| 49 | synapse assembly (GO:0007416) | 3.37185013 |
| 50 | positive regulation of synapse assembly (GO:0051965) | 3.36017063 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.35649920 |
| 52 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.31185446 |
| 53 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.30159091 |
| 54 | regulation of protein kinase A signaling (GO:0010738) | 3.29036056 |
| 55 | negative regulation of amino acid transport (GO:0051956) | 3.28217567 |
| 56 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.27138149 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.26366676 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.23176041 |
| 59 | neuronal action potential (GO:0019228) | 3.22919716 |
| 60 | mating behavior (GO:0007617) | 3.22348799 |
| 61 | gamma-aminobutyric acid transport (GO:0015812) | 3.21713027 |
| 62 | long-term synaptic potentiation (GO:0060291) | 3.18090866 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.17423087 |
| 64 | prepulse inhibition (GO:0060134) | 3.16904608 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.15997763 |
| 66 | neurotransmitter transport (GO:0006836) | 3.15167763 |
| 67 | L-fucose catabolic process (GO:0042355) | 3.12137863 |
| 68 | fucose catabolic process (GO:0019317) | 3.12137863 |
| 69 | L-fucose metabolic process (GO:0042354) | 3.12137863 |
| 70 | membrane depolarization (GO:0051899) | 3.11203353 |
| 71 | long-term memory (GO:0007616) | 3.08191282 |
| 72 | behavioral response to ethanol (GO:0048149) | 3.08086743 |
| 73 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.07958951 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.07646231 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.04993922 |
| 76 | regulation of synapse structural plasticity (GO:0051823) | 3.04449217 |
| 77 | maternal behavior (GO:0042711) | 3.02822594 |
| 78 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.01955162 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.01595394 |
| 80 | regulation of neurotransmitter levels (GO:0001505) | 3.00949199 |
| 81 | membrane hyperpolarization (GO:0060081) | 3.00496869 |
| 82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99575080 |
| 83 | primary amino compound metabolic process (GO:1901160) | 2.98095479 |
| 84 | response to pheromone (GO:0019236) | 2.95344820 |
| 85 | dendrite morphogenesis (GO:0048813) | 2.93647968 |
| 86 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91455877 |
| 87 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91455877 |
| 88 | intraspecies interaction between organisms (GO:0051703) | 2.91280733 |
| 89 | social behavior (GO:0035176) | 2.91280733 |
| 90 | auditory behavior (GO:0031223) | 2.90519438 |
| 91 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.88619430 |
| 92 | opioid receptor signaling pathway (GO:0038003) | 2.87636486 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87403190 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.85840452 |
| 95 | C4-dicarboxylate transport (GO:0015740) | 2.85378910 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.85330374 |
| 97 | regulation of neurotransmitter transport (GO:0051588) | 2.85173810 |
| 98 | activation of protein kinase A activity (GO:0034199) | 2.84565610 |
| 99 | positive regulation of synapse maturation (GO:0090129) | 2.83491173 |
| 100 | regulation of synapse assembly (GO:0051963) | 2.83105765 |
| 101 | membrane depolarization during action potential (GO:0086010) | 2.83025848 |
| 102 | synaptic vesicle endocytosis (GO:0048488) | 2.81757298 |
| 103 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81638823 |
| 104 | response to auditory stimulus (GO:0010996) | 2.81147091 |
| 105 | regulation of synaptic plasticity (GO:0048167) | 2.81000653 |
| 106 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.80594067 |
| 107 | detection of light stimulus involved in visual perception (GO:0050908) | 2.80594067 |
| 108 | multi-organism reproductive behavior (GO:0044705) | 2.79861166 |
| 109 | synapse organization (GO:0050808) | 2.79833964 |
| 110 | positive regulation of neurotransmitter transport (GO:0051590) | 2.78520738 |
| 111 | learning (GO:0007612) | 2.78247081 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.77702807 |
| 113 | response to amphetamine (GO:0001975) | 2.77427040 |
| 114 | synaptic transmission (GO:0007268) | 2.75759455 |
| 115 | reflex (GO:0060004) | 2.72539484 |
| 116 | DNA double-strand break processing (GO:0000729) | 2.70947931 |
| 117 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.70613025 |
| 118 | limb bud formation (GO:0060174) | 2.70530360 |
| 119 | central nervous system myelination (GO:0022010) | 2.67581676 |
| 120 | axon ensheathment in central nervous system (GO:0032291) | 2.67581676 |
| 121 | retinal cone cell development (GO:0046549) | 2.67398769 |
| 122 | positive regulation of meiosis (GO:0045836) | 2.64139609 |
| 123 | nucleobase catabolic process (GO:0046113) | 2.63135717 |
| 124 | somite development (GO:0061053) | 2.60000899 |
| 125 | indolalkylamine metabolic process (GO:0006586) | 2.56163542 |
| 126 | regulation of action potential (GO:0098900) | 2.55647725 |
| 127 | tachykinin receptor signaling pathway (GO:0007217) | 2.55630201 |
| 128 | epithelial cilium movement (GO:0003351) | 2.55339313 |
| 129 | mechanosensory behavior (GO:0007638) | 2.54516844 |
| 130 | regulation of neurotransmitter uptake (GO:0051580) | 2.54279893 |
| 131 | neuromuscular synaptic transmission (GO:0007274) | 2.53493005 |
| 132 | retina layer formation (GO:0010842) | 2.53473693 |
| 133 | glycosphingolipid biosynthetic process (GO:0006688) | 2.52482810 |
| 134 | nephron epithelium morphogenesis (GO:0072088) | 2.52350654 |
| 135 | nephron tubule morphogenesis (GO:0072078) | 2.52350654 |
| 136 | DNA deamination (GO:0045006) | 2.52303636 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.52303157 |
| 138 | nonmotile primary cilium assembly (GO:0035058) | 2.52056409 |
| 139 | negative regulation of astrocyte differentiation (GO:0048712) | 2.51194278 |
| 140 | cilium morphogenesis (GO:0060271) | 2.47435986 |
| 141 | platelet dense granule organization (GO:0060155) | 2.47011876 |
| 142 | cochlea development (GO:0090102) | 2.46722097 |
| 143 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.46622992 |
| 144 | action potential (GO:0001508) | 2.45559521 |
| 145 | synaptic transmission, cholinergic (GO:0007271) | 2.45172579 |
| 146 | regulation of collateral sprouting (GO:0048670) | 2.43522002 |
| 147 | positive regulation of meiotic cell cycle (GO:0051446) | 2.43382471 |
| 148 | axoneme assembly (GO:0035082) | 2.42833656 |
| 149 | kidney morphogenesis (GO:0060993) | 2.41383706 |
| 150 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.41247693 |
| 151 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.40559749 |
| 152 | indole-containing compound catabolic process (GO:0042436) | 2.40297297 |
| 153 | indolalkylamine catabolic process (GO:0046218) | 2.40297297 |
| 154 | tryptophan catabolic process (GO:0006569) | 2.40297297 |
| 155 | negative regulation of telomere maintenance (GO:0032205) | 2.40155158 |
| 156 | photoreceptor cell development (GO:0042461) | 2.38633692 |
| 157 | regulation of mesoderm development (GO:2000380) | 2.37166151 |
| 158 | behavioral defense response (GO:0002209) | 2.35402389 |
| 159 | behavioral fear response (GO:0001662) | 2.35402389 |
| 160 | protein polyglutamylation (GO:0018095) | 2.35280877 |
| 161 | renal tubule morphogenesis (GO:0061333) | 2.34714723 |
| 162 | otic vesicle formation (GO:0030916) | 2.33982108 |
| 163 | inner ear receptor stereocilium organization (GO:0060122) | 2.33904749 |
| 164 | protein localization to cilium (GO:0061512) | 2.33404947 |
| 165 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.33058627 |
| 166 | neural tube formation (GO:0001841) | 2.32972535 |
| 167 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.32809233 |
| 168 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.32024178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.96827556 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.26850101 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94778828 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84092492 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80217007 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58330309 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56310630 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48014575 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.44176966 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42934019 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39306748 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39306748 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37274833 |
| 14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29644906 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.28056201 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26042542 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25716497 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23712802 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18472155 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14958116 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12375532 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.10263808 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.07541847 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00576291 |
| 25 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96429989 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93352715 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93251027 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86759126 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86450216 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86070663 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85437713 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84024302 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82839630 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81743660 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79961024 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77335723 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77001066 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72732127 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68189487 |
| 40 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67662245 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.67440448 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.64897358 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63911521 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63764041 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63540778 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.63063388 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63014738 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61848053 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58419978 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.57292552 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54485348 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51026545 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50738354 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50534604 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50196100 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47601579 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47389309 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45820266 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.45298716 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45201982 |
| 61 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43243696 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41314115 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40150713 |
| 64 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39207569 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34722808 |
| 66 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33984620 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33200320 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33200320 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32456261 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31449367 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30304134 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29234900 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28004258 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27389569 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27202121 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.26963701 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25922333 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25835154 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24170154 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24020909 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23451357 |
| 82 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22141990 |
| 83 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21601378 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21314994 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21049780 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20966461 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19685068 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19564127 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19208310 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18741120 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18573227 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18573227 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17942452 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17800781 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17208705 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16891027 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14900537 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14602621 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12062623 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11987554 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11491822 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11107168 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10606581 |
| 104 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09362789 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08386190 |
| 106 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08102018 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06193564 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05921864 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05610746 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 1.05090739 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04223204 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03142214 |
| 113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03142214 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02795471 |
| 115 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01881408 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01841322 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01774049 |
| 118 | AR_19668381_ChIP-Seq_PC3_Human | 1.01507808 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01487620 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00597624 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00297777 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98857895 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98192677 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97974928 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94269440 |
| 126 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92596486 |
| 127 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.91658485 |
| 128 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91179117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.99771676 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.72437543 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.92319389 |
| 4 | MP0004270_analgesia | 3.79334711 |
| 5 | MP0009046_muscle_twitch | 3.56095831 |
| 6 | MP0009745_abnormal_behavioral_response | 3.54762089 |
| 7 | MP0002064_seizures | 3.26027144 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.15781105 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.03338237 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.95353795 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.83366467 |
| 12 | MP0001440_abnormal_grooming_behavior | 2.64397402 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.61525528 |
| 14 | MP0001486_abnormal_startle_reflex | 2.57380028 |
| 15 | MP0002272_abnormal_nervous_system | 2.55154580 |
| 16 | MP0002102_abnormal_ear_morphology | 2.53880430 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.50643193 |
| 18 | MP0002736_abnormal_nociception_after | 2.39957338 |
| 19 | MP0001188_hyperpigmentation | 2.35120947 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.27554535 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.26529086 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.23905989 |
| 23 | MP0003136_yellow_coat_color | 2.23431847 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.15367041 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.14753405 |
| 26 | MP0002184_abnormal_innervation | 2.13465967 |
| 27 | MP0000778_abnormal_nervous_system | 2.13451976 |
| 28 | MP0002735_abnormal_chemical_nociception | 2.10780361 |
| 29 | MP0001984_abnormal_olfaction | 2.04406174 |
| 30 | MP0001970_abnormal_pain_threshold | 2.01792100 |
| 31 | MP0001529_abnormal_vocalization | 1.99917688 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.98748029 |
| 33 | MP0004924_abnormal_behavior | 1.98748029 |
| 34 | MP0002822_catalepsy | 1.92371820 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.84775007 |
| 36 | MP0004133_heterotaxia | 1.78310771 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.77732954 |
| 38 | MP0004142_abnormal_muscle_tone | 1.76196972 |
| 39 | MP0003122_maternal_imprinting | 1.71727314 |
| 40 | MP0003195_calcinosis | 1.67574696 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.65570760 |
| 42 | MP0001905_abnormal_dopamine_level | 1.65005858 |
| 43 | MP0005253_abnormal_eye_physiology | 1.63679074 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.61227400 |
| 45 | MP0008569_lethality_at_weaning | 1.58042856 |
| 46 | MP0004510_myositis | 1.57900116 |
| 47 | MP0002938_white_spotting | 1.47913403 |
| 48 | MP0003890_abnormal_embryonic-extraembry | 1.46473887 |
| 49 | MP0004742_abnormal_vestibular_system | 1.43332041 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.42630980 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.41431980 |
| 52 | MP0003879_abnormal_hair_cell | 1.41086759 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.40367954 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.39468036 |
| 55 | MP0003283_abnormal_digestive_organ | 1.37572321 |
| 56 | MP0002882_abnormal_neuron_morphology | 1.35550601 |
| 57 | MP0000955_abnormal_spinal_cord | 1.30524849 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.25439542 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.23644283 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.23375458 |
| 61 | MP0003329_amyloid_beta_deposits | 1.22659307 |
| 62 | MP0003787_abnormal_imprinting | 1.21802626 |
| 63 | MP0005171_absent_coat_pigmentation | 1.19137076 |
| 64 | MP0003119_abnormal_digestive_system | 1.16080585 |
| 65 | MP0004147_increased_porphyrin_level | 1.15308439 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.12883508 |
| 67 | MP0003937_abnormal_limbs/digits/tail_de | 1.11275761 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.08994025 |
| 69 | MP0000427_abnormal_hair_cycle | 1.07836217 |
| 70 | MP0000049_abnormal_middle_ear | 1.07584443 |
| 71 | MP0003633_abnormal_nervous_system | 1.07154174 |
| 72 | MP0003011_delayed_dark_adaptation | 1.06600634 |
| 73 | MP0002234_abnormal_pharynx_morphology | 1.06285300 |
| 74 | MP0004885_abnormal_endolymph | 1.03035288 |
| 75 | MP0002152_abnormal_brain_morphology | 1.02573252 |
| 76 | MP0008872_abnormal_physiological_respon | 1.02510323 |
| 77 | MP0003303_peritoneal_inflammation | 1.00986771 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.00334775 |
| 79 | MP0004145_abnormal_muscle_electrophysio | 1.00092308 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.98406153 |
| 81 | MP0000604_amyloidosis | 0.98117941 |
| 82 | MP0003631_nervous_system_phenotype | 0.97529458 |
| 83 | MP0004043_abnormal_pH_regulation | 0.97459290 |
| 84 | MP0005195_abnormal_posterior_eye | 0.96558677 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.96425373 |
| 86 | MP0002163_abnormal_gland_morphology | 0.95284198 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 0.93767005 |
| 88 | MP0004858_abnormal_nervous_system | 0.93520958 |
| 89 | MP0005409_darkened_coat_color | 0.93501400 |
| 90 | MP0003646_muscle_fatigue | 0.93389495 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.93275047 |
| 92 | MP0002751_abnormal_autonomic_nervous | 0.92232281 |
| 93 | MP0008874_decreased_physiological_sensi | 0.91863237 |
| 94 | MP0003938_abnormal_ear_development | 0.89856017 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.89403953 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.88618333 |
| 97 | MP0002229_neurodegeneration | 0.88066777 |
| 98 | MP0003634_abnormal_glial_cell | 0.86680402 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.83124916 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.81254857 |
| 101 | MP0005310_abnormal_salivary_gland | 0.80836775 |
| 102 | MP0001324_abnormal_eye_pigmentation | 0.80627561 |
| 103 | MP0003690_abnormal_glial_cell | 0.80019576 |
| 104 | MP0004085_abnormal_heartbeat | 0.79909796 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.78874850 |
| 106 | MP0000647_abnormal_sebaceous_gland | 0.78273474 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.78014496 |
| 108 | MP0002928_abnormal_bile_duct | 0.77694722 |
| 109 | MP0000920_abnormal_myelination | 0.77469592 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.77295615 |
| 111 | MP0005535_abnormal_body_temperature | 0.77131333 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.77095861 |
| 113 | MP0001293_anophthalmia | 0.77029759 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.76879248 |
| 115 | MP0000566_synostosis | 0.76660528 |
| 116 | MP0000383_abnormal_hair_follicle | 0.75571728 |
| 117 | MP0003632_abnormal_nervous_system | 0.74400059 |
| 118 | MP0003137_abnormal_impulse_conducting | 0.74397828 |
| 119 | MP0009379_abnormal_foot_pigmentation | 0.73598926 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.73373016 |
| 121 | MP0002160_abnormal_reproductive_system | 0.73147212 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.72437922 |
| 123 | MP0005394_taste/olfaction_phenotype | 0.72354110 |
| 124 | MP0005499_abnormal_olfactory_system | 0.72354110 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.71143081 |
| 126 | MP0005551_abnormal_eye_electrophysiolog | 0.70402377 |
| 127 | MP0002090_abnormal_vision | 0.66976334 |
| 128 | MP0001943_abnormal_respiration | 0.65849195 |
| 129 | MP0000751_myopathy | 0.63113113 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.57884498 |
| 131 | MP0000026_abnormal_inner_ear | 0.57594814 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.57197903 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.55420376 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.54185949 |
| 135 | MP0001346_abnormal_lacrimal_gland | 0.51473826 |
| 136 | MP0003121_genomic_imprinting | 0.50770882 |
| 137 | MP0010770_preweaning_lethality | 0.49024367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.27988961 |
| 2 | Atonic seizures (HP:0010819) | 5.87601255 |
| 3 | Focal seizures (HP:0007359) | 5.86846303 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.16705251 |
| 5 | Febrile seizures (HP:0002373) | 4.97118434 |
| 6 | Myokymia (HP:0002411) | 4.83497684 |
| 7 | Absence seizures (HP:0002121) | 4.77678625 |
| 8 | Visual hallucinations (HP:0002367) | 4.57802521 |
| 9 | Dialeptic seizures (HP:0011146) | 4.51274869 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.37126723 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.35824443 |
| 12 | Pancreatic cysts (HP:0001737) | 3.97297875 |
| 13 | Limb dystonia (HP:0002451) | 3.89630033 |
| 14 | True hermaphroditism (HP:0010459) | 3.77717686 |
| 15 | Broad-based gait (HP:0002136) | 3.71845345 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 3.70213220 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.70213220 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.70209934 |
| 19 | Hypothermia (HP:0002045) | 3.63659322 |
| 20 | Hyperventilation (HP:0002883) | 3.60364361 |
| 21 | Truncal ataxia (HP:0002078) | 3.45007076 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.39815658 |
| 23 | Excessive salivation (HP:0003781) | 3.29601202 |
| 24 | Drooling (HP:0002307) | 3.29601202 |
| 25 | Nephronophthisis (HP:0000090) | 3.28927471 |
| 26 | Mutism (HP:0002300) | 3.25652852 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.10591002 |
| 28 | Polyphagia (HP:0002591) | 2.97703407 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.95013187 |
| 30 | Amblyopia (HP:0000646) | 2.89111361 |
| 31 | Abnormal hair whorl (HP:0010721) | 2.86872405 |
| 32 | Abnormality of the renal medulla (HP:0100957) | 2.84570112 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.78660795 |
| 34 | Type II lissencephaly (HP:0007260) | 2.76910467 |
| 35 | Fetal akinesia sequence (HP:0001989) | 2.74927598 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.71578854 |
| 37 | Progressive inability to walk (HP:0002505) | 2.70134827 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 2.69641800 |
| 39 | Inappropriate behavior (HP:0000719) | 2.65352489 |
| 40 | Cystic liver disease (HP:0006706) | 2.64129531 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.58004996 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 2.55805779 |
| 43 | Action tremor (HP:0002345) | 2.54620781 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.54180606 |
| 45 | Gait imbalance (HP:0002141) | 2.52086428 |
| 46 | Protruding tongue (HP:0010808) | 2.50978675 |
| 47 | Impaired smooth pursuit (HP:0007772) | 2.50953199 |
| 48 | Poor eye contact (HP:0000817) | 2.48610031 |
| 49 | Agitation (HP:0000713) | 2.48041980 |
| 50 | Abnormality of salivation (HP:0100755) | 2.47441815 |
| 51 | Akinesia (HP:0002304) | 2.47121859 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.45271261 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.44692309 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.43387561 |
| 55 | Dysmetria (HP:0001310) | 2.42985083 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.42207168 |
| 57 | Abnormality of the labia minora (HP:0012880) | 2.41151032 |
| 58 | Stereotypic behavior (HP:0000733) | 2.40404517 |
| 59 | Dysmetric saccades (HP:0000641) | 2.39117415 |
| 60 | Hyperthyroidism (HP:0000836) | 2.38876086 |
| 61 | Hemiparesis (HP:0001269) | 2.38237802 |
| 62 | Scanning speech (HP:0002168) | 2.35691985 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.33273445 |
| 64 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.30021097 |
| 65 | Status epilepticus (HP:0002133) | 2.29301040 |
| 66 | Failure to thrive in infancy (HP:0001531) | 2.29253221 |
| 67 | Lissencephaly (HP:0001339) | 2.27274052 |
| 68 | Diplopia (HP:0000651) | 2.26961878 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.26961878 |
| 70 | Decreased central vision (HP:0007663) | 2.25316945 |
| 71 | Keratoconus (HP:0000563) | 2.24306445 |
| 72 | Increased corneal curvature (HP:0100692) | 2.24306445 |
| 73 | Insidious onset (HP:0003587) | 2.23177111 |
| 74 | Termporal pattern (HP:0011008) | 2.23177111 |
| 75 | Tubular atrophy (HP:0000092) | 2.22499222 |
| 76 | Genetic anticipation (HP:0003743) | 2.22072993 |
| 77 | Sclerocornea (HP:0000647) | 2.21482423 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.20602306 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.20602306 |
| 80 | Psychosis (HP:0000709) | 2.18204561 |
| 81 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17412246 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.16645003 |
| 83 | Optic nerve hypoplasia (HP:0000609) | 2.16265610 |
| 84 | Pendular nystagmus (HP:0012043) | 2.15521933 |
| 85 | Anxiety (HP:0000739) | 2.15465086 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.15433438 |
| 87 | Papilledema (HP:0001085) | 2.15334730 |
| 88 | Impaired social interactions (HP:0000735) | 2.14385333 |
| 89 | Abnormal social behavior (HP:0012433) | 2.14385333 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.13826589 |
| 91 | Attenuation of retinal blood vessels (HP:0007843) | 2.13320639 |
| 92 | Abnormal ciliary motility (HP:0012262) | 2.12407077 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.12339712 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.12339712 |
| 95 | Exotropia (HP:0000577) | 2.12105923 |
| 96 | Genital tract atresia (HP:0001827) | 2.11237794 |
| 97 | Inability to walk (HP:0002540) | 2.10942185 |
| 98 | Intestinal atresia (HP:0011100) | 2.09402727 |
| 99 | Polydipsia (HP:0001959) | 2.08828615 |
| 100 | Abnormal drinking behavior (HP:0030082) | 2.08828615 |
| 101 | Blue irides (HP:0000635) | 2.07555221 |
| 102 | Vaginal atresia (HP:0000148) | 2.07552609 |
| 103 | Depression (HP:0000716) | 2.06356082 |
| 104 | Concave nail (HP:0001598) | 2.04623110 |
| 105 | Hypoventilation (HP:0002791) | 2.04315235 |
| 106 | Anencephaly (HP:0002323) | 2.04037050 |
| 107 | Specific learning disability (HP:0001328) | 2.03414740 |
| 108 | Torticollis (HP:0000473) | 2.03377862 |
| 109 | Medial flaring of the eyebrow (HP:0010747) | 2.01600373 |
| 110 | Pheochromocytoma (HP:0002666) | 2.01532086 |
| 111 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.01268054 |
| 112 | Congenital, generalized hypertrichosis (HP:0004540) | 1.99914135 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99822831 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.99822831 |
| 115 | Hyperalaninemia (HP:0003348) | 1.99822831 |
| 116 | Fair hair (HP:0002286) | 1.98982470 |
| 117 | Neuroendocrine neoplasm (HP:0100634) | 1.98961493 |
| 118 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.98296806 |
| 119 | Postural tremor (HP:0002174) | 1.98175641 |
| 120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97429286 |
| 121 | Congenital primary aphakia (HP:0007707) | 1.97340919 |
| 122 | Furrowed tongue (HP:0000221) | 1.96957654 |
| 123 | Absent speech (HP:0001344) | 1.96386345 |
| 124 | Hypsarrhythmia (HP:0002521) | 1.95511302 |
| 125 | Urinary urgency (HP:0000012) | 1.95329993 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 1.94919700 |
| 127 | Retrobulbar optic neuritis (HP:0100654) | 1.92286816 |
| 128 | Optic neuritis (HP:0100653) | 1.92286816 |
| 129 | Spastic gait (HP:0002064) | 1.90985101 |
| 130 | Heterochromia iridis (HP:0001100) | 1.90899203 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89457186 |
| 132 | Renal cortical cysts (HP:0000803) | 1.88720314 |
| 133 | Postural instability (HP:0002172) | 1.86710083 |
| 134 | Preaxial hand polydactyly (HP:0001177) | 1.85601554 |
| 135 | Disinhibition (HP:0000734) | 1.84292409 |
| 136 | Short hallux (HP:0010109) | 1.84140388 |
| 137 | Ankle clonus (HP:0011448) | 1.84101761 |
| 138 | Colon cancer (HP:0003003) | 1.83566671 |
| 139 | Incomplete penetrance (HP:0003829) | 1.83193582 |
| 140 | Esotropia (HP:0000565) | 1.82998049 |
| 141 | Lower limb asymmetry (HP:0100559) | 1.82474462 |
| 142 | Lower limb muscle weakness (HP:0007340) | 1.82268477 |
| 143 | Chorioretinal atrophy (HP:0000533) | 1.82004035 |
| 144 | Progressive macrocephaly (HP:0004481) | 1.81144465 |
| 145 | Polyuria (HP:0000103) | 1.81008965 |
| 146 | Postaxial foot polydactyly (HP:0001830) | 1.80423477 |
| 147 | Acute necrotizing encephalopathy (HP:0006965) | 1.80371311 |
| 148 | Congenital hepatic fibrosis (HP:0002612) | 1.79020108 |
| 149 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78882116 |
| 150 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.78838936 |
| 151 | Cerebellar dysplasia (HP:0007033) | 1.77275423 |
| 152 | Abnormal biliary tract physiology (HP:0012439) | 1.76591245 |
| 153 | Bile duct proliferation (HP:0001408) | 1.76591245 |
| 154 | Pachygyria (HP:0001302) | 1.76231537 |
| 155 | Postaxial hand polydactyly (HP:0001162) | 1.75701354 |
| 156 | Preaxial foot polydactyly (HP:0001841) | 1.73989768 |
| 157 | Male pseudohermaphroditism (HP:0000037) | 1.73079174 |
| 158 | Large for gestational age (HP:0001520) | 1.68612415 |
| 159 | Abnormality of macular pigmentation (HP:0008002) | 1.68524227 |
| 160 | Stenosis of the external auditory canal (HP:0000402) | 1.68042882 |
| 161 | Stomach cancer (HP:0012126) | 1.67157890 |
| 162 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.66379080 |
| 163 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.66379080 |
| 164 | Oligodactyly (hands) (HP:0001180) | 1.65991304 |
| 165 | Ectopic kidney (HP:0000086) | 1.64874884 |
| 166 | Septo-optic dysplasia (HP:0100842) | 1.64463159 |
| 167 | Gastrointestinal atresia (HP:0002589) | 1.61410018 |
| 168 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.61109618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.35602845 |
| 2 | CASK | 4.26630104 |
| 3 | MARK1 | 3.23340322 |
| 4 | MAP3K9 | 2.70910195 |
| 5 | MAP2K7 | 2.69185850 |
| 6 | MAP3K4 | 2.64128671 |
| 7 | MAP3K12 | 2.50083748 |
| 8 | RIPK4 | 2.48650478 |
| 9 | TNIK | 2.44158894 |
| 10 | PRPF4B | 2.41630352 |
| 11 | MINK1 | 2.40875752 |
| 12 | NUAK1 | 2.34815056 |
| 13 | PINK1 | 2.20129660 |
| 14 | DAPK2 | 2.13495686 |
| 15 | GRK1 | 2.12211279 |
| 16 | BMPR2 | 2.09152898 |
| 17 | EPHA4 | 2.07067064 |
| 18 | CDK19 | 1.95876639 |
| 19 | CAMKK2 | 1.94152715 |
| 20 | MAPK13 | 1.93758378 |
| 21 | TRIM28 | 1.93241088 |
| 22 | PLK2 | 1.89664899 |
| 23 | MAP4K2 | 1.89274349 |
| 24 | ACVR1B | 1.86053417 |
| 25 | NTRK2 | 1.77871220 |
| 26 | MAP2K4 | 1.72598415 |
| 27 | ZAK | 1.68271787 |
| 28 | SIK3 | 1.55946737 |
| 29 | GRK5 | 1.54663291 |
| 30 | AKT3 | 1.52655223 |
| 31 | SIK2 | 1.52015318 |
| 32 | INSRR | 1.50360955 |
| 33 | DAPK1 | 1.44932410 |
| 34 | PAK6 | 1.42402368 |
| 35 | KSR1 | 1.39830057 |
| 36 | MKNK2 | 1.36286116 |
| 37 | ARAF | 1.31162565 |
| 38 | FES | 1.30698447 |
| 39 | CDK5 | 1.27956931 |
| 40 | BCR | 1.25212136 |
| 41 | OXSR1 | 1.24990494 |
| 42 | CAMK2A | 1.23494103 |
| 43 | ERBB3 | 1.23262044 |
| 44 | PNCK | 1.20068175 |
| 45 | CAMKK1 | 1.18065118 |
| 46 | WNK4 | 1.17471194 |
| 47 | TAOK3 | 1.11311230 |
| 48 | TLK1 | 1.10659395 |
| 49 | SGK2 | 1.08711459 |
| 50 | PRKCG | 1.07458225 |
| 51 | WEE1 | 1.06106955 |
| 52 | BMPR1B | 1.04837643 |
| 53 | TSSK6 | 1.01695457 |
| 54 | FGR | 1.00681316 |
| 55 | KSR2 | 1.00451976 |
| 56 | SGK494 | 0.96879799 |
| 57 | SGK223 | 0.96879799 |
| 58 | VRK1 | 0.95348626 |
| 59 | PLK3 | 0.93641537 |
| 60 | CSNK1G2 | 0.93204982 |
| 61 | NTRK1 | 0.91720165 |
| 62 | CAMK2B | 0.90656005 |
| 63 | PTK2B | 0.89896900 |
| 64 | CSNK1G1 | 0.89286821 |
| 65 | TGFBR1 | 0.87652034 |
| 66 | MAPK15 | 0.86998369 |
| 67 | TAF1 | 0.85249504 |
| 68 | PAK3 | 0.84989390 |
| 69 | PKN1 | 0.84302917 |
| 70 | GRK7 | 0.83039777 |
| 71 | ADRBK2 | 0.80888367 |
| 72 | CDK14 | 0.80741502 |
| 73 | CDK18 | 0.77814111 |
| 74 | PLK4 | 0.77153364 |
| 75 | CSNK1A1L | 0.75748309 |
| 76 | UHMK1 | 0.75538557 |
| 77 | MAP3K13 | 0.75135160 |
| 78 | PRKCE | 0.74038526 |
| 79 | DYRK1A | 0.73562963 |
| 80 | TXK | 0.72905414 |
| 81 | PHKG2 | 0.72674316 |
| 82 | PHKG1 | 0.72674316 |
| 83 | STK24 | 0.72012085 |
| 84 | ADRBK1 | 0.71858846 |
| 85 | CDK15 | 0.70651841 |
| 86 | MKNK1 | 0.69452814 |
| 87 | STK11 | 0.69210582 |
| 88 | EPHA3 | 0.66283226 |
| 89 | SGK1 | 0.62571970 |
| 90 | RPS6KA2 | 0.61711302 |
| 91 | CAMK2D | 0.60987486 |
| 92 | STK38L | 0.59865012 |
| 93 | RET | 0.59646577 |
| 94 | MAPKAPK5 | 0.59106075 |
| 95 | CSNK1G3 | 0.58575059 |
| 96 | SGK3 | 0.56956345 |
| 97 | CDK11A | 0.56701431 |
| 98 | STK3 | 0.55727853 |
| 99 | MUSK | 0.55230919 |
| 100 | IRAK1 | 0.55090387 |
| 101 | NLK | 0.53881666 |
| 102 | FRK | 0.53318757 |
| 103 | CSNK1A1 | 0.52386413 |
| 104 | BRAF | 0.52178882 |
| 105 | DAPK3 | 0.50677543 |
| 106 | FGFR2 | 0.50425577 |
| 107 | CAMK2G | 0.48250245 |
| 108 | DYRK2 | 0.47907216 |
| 109 | PIK3CA | 0.45484908 |
| 110 | TIE1 | 0.45300841 |
| 111 | PRKCH | 0.45246766 |
| 112 | PRKCZ | 0.44979245 |
| 113 | CCNB1 | 0.44328389 |
| 114 | CSNK1D | 0.43590548 |
| 115 | PRKG1 | 0.43558839 |
| 116 | MAP2K6 | 0.42632399 |
| 117 | FYN | 0.41880377 |
| 118 | ERBB2 | 0.41832029 |
| 119 | YES1 | 0.41548250 |
| 120 | MAP3K2 | 0.41431137 |
| 121 | STK16 | 0.41189748 |
| 122 | CDC42BPA | 0.40889224 |
| 123 | WNK3 | 0.40770320 |
| 124 | PRKCB | 0.40643838 |
| 125 | MST4 | 0.40634757 |
| 126 | MAP3K14 | 0.38492395 |
| 127 | RPS6KA3 | 0.38368727 |
| 128 | STK39 | 0.37697077 |
| 129 | WNK1 | 0.37450884 |
| 130 | SCYL2 | 0.36735799 |
| 131 | CDK3 | 0.36702519 |
| 132 | CDC7 | 0.36657540 |
| 133 | CAMK4 | 0.36619630 |
| 134 | MAP2K1 | 0.36168843 |
| 135 | PRKACA | 0.35922099 |
| 136 | PRKCA | 0.34905611 |
| 137 | BRSK2 | 0.33795309 |
| 138 | MAPK12 | 0.33608672 |
| 139 | CAMK1 | 0.33511227 |
| 140 | LATS2 | 0.33481356 |
| 141 | PLK1 | 0.33405605 |
| 142 | BCKDK | 0.33260749 |
| 143 | NME1 | 0.30924953 |
| 144 | MARK2 | 0.30871631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.02704219 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.19310076 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.78455618 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.62649305 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.52118837 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50567176 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45436250 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.43135940 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41537300 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.39528818 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.37422822 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.24577501 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.11785753 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09637936 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.00201445 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86041345 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.83819793 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.83681064 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.83617780 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77874992 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76988341 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.70297107 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.70002802 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.69104218 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.67608046 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.56324155 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54033140 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53521575 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53018661 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52619781 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50312305 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47171104 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45039182 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44077399 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43766284 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43150597 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41078966 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39640405 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.37157705 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.36651844 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33125415 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32306928 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29515852 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25042618 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.23775598 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22210031 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20468774 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19744276 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18079956 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16650135 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15952048 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15266963 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.15094994 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.12448622 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.11096540 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.10124838 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09819444 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08668530 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06199993 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04779924 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04706395 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01093156 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00898428 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00025017 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99985856 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98691069 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.98602016 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95632526 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93442503 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91646635 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.91234732 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.87438466 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87437614 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.86294797 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84983849 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83104342 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80233021 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79018678 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78765954 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77335641 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75859773 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.73379668 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71960421 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71930996 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68903976 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68894497 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68378947 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.68176932 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67844553 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67699413 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67657681 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65401777 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64449345 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63553037 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.62106280 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61610038 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60547508 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60144355 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60105979 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59620837 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59603179 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59222711 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58424382 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58056368 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58053739 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57548446 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56841402 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56692205 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56248050 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54545016 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53550906 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.51285061 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50282395 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49674485 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49035689 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48055573 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47727128 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47301748 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46820033 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46506397 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46327302 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46264702 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46183612 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45350889 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44823288 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44438043 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43445803 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43171960 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42864806 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42771184 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.41296374 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41053634 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40800554 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40521131 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40130080 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39628477 |
| 137 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39366810 |
| 138 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39193671 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39049890 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38461911 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.38251574 |
| 142 | Melanoma_Homo sapiens_hsa05218 | 0.37712363 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.37680596 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34747000 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33284941 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32664045 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32492115 |
| 148 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32476139 |
| 149 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30923295 |
| 150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.30662157 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30543948 |

